MedAssets, Inc. (NASDAQ:

) today announced results for its fourth quarter and 12-month period ended December 31, 2010, as summarized below: Net Revenue Fourth Quarter Total net revenue for the fourth quarter of 2010 increased 11.8% to $106.9 million from $95.7 million in the fourth quarter of 2009. RCM segment growth of 4.1% was driven by an increase in technology solutions revenue, offset by a decline in services revenue and decision support license fees. Revenue growth of 22.8% in the SM segment was driven by 46 days of revenue from The Broadlane Group (Broadlane), continued strong demand for medical device and clinical consulting services, and growth in group purchasing-related net administrative fees. Comparing period-over-period organic growth, the Company's non-GAAP acquisition-affected total net revenue for the fourth quarter of 2010 increased 1.3% to $142.4 million from non-GAAP acquisition-affected total net revenue of $140.5 million in the same period of 2009. 12-month Period Total net revenue for the year ended December 31, 2010 increased 14.7% to $391.3 million from $341.3 million in 2009. Comparing period-over-period organic growth, the Company's non-GAAP acquisition-affected total net revenue for full-year 2010 increased 9.6% to $557.4 million from non-GAAP acquisition-affected total net revenue of $508.8 million in the same period of 2009.